Kromek Group plc share price, company news, analysis and interviews

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured a repeat order, worth $0.8m, from a US government customer for its D3S ID wearable nuclear radiation detector. Delivery and revenue recognition is expected to occur in the Group’s current financial year. D3S ID gamma neutron detector The D3S ID gamma neutron detector is a wearable Radiation Isotope Identifier (“RIID”) designed for first responders, armed forces, border security and other CBRN experts. Unlike a conventional RIID, it is a pocket-sized device and is small and light enough

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has entered into a distribution agreement with Smiths Detection, a global leader in threat detection and security screening technologies. Under the terms of the agreement, Smiths Detection will market and distribute the Group’s wearable radiation detection and identification solutions in the Middle East and certain key markets in Asia and Australasia. This expands the Group’s existing agreement, as announced on 7 July 2022, with Smiths Detection Inc. for distribution in North and South American markets. To date, the Group

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured two contracts, totalling £1.5m, for the supply of its D3M and D3S-based nuclear security products. Delivery will commence immediately and the revenue will be received in Kromek’s current financial year. Both contracts have been secured with Kromek distribution and procurement partners, and are to supply European government end-users. Kromek’s nuclear security products help guard against the threat of nuclear terrorism, accidents and the illicit movement of nuclear materials. The contracts are for Kromek’s D3M, D3 static node and

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured a contract with a UK Government department to develop and supply biological threat detection systems. Under the terms of the contract, Kromek will commence work in December for a three-year programme worth £4.9m. The contract also includes an option for extended maintenance services after the initial term. Arnab Basu, CEO of Kromek Group, said: “We are delighted to have been awarded this contract to develop and supply an important capability for biological threat detection. The pandemic has demonstrated the